Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help Dads-to-Be bond and beat anxiety?

NCT ID NCT07767045

Symptom relief Sponsor: Ege University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This study tests whether an 8-week mobile app program, based on Transition Theory, can help first-time expectant fathers reduce anxiety, strengthen their bond with the unborn baby, and improve marital adjustment. About 96 fathers whose partners are 26-28 weeks pregnant will be randomly assigned to either use the app or receive no intervention. Researchers will compare changes in anxiety, fetal bonding, and relationship quality between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mobile app-based educational program for expectant fathers
What this could lead to
If effective, this app-based support could become a simple, scalable way to help first-time fathers feel less anxious, bond with their unborn baby, and strengthen their relationship with their partner during pregnancy.
What could go wrong
This is a small, early-stage trial with 96 participants, so results may not apply to all fathers. The app's benefits are uncertain, and it requires a smartphone and willingness to engage, which may limit its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be 18 years of age or older and able to speak and understand Turkish * Have completed at least elementary school * Your spouse must be between the 26th and 28th weeks of pregnancy * This must be the first parenting experience for both you and your spouse * Own a smartphone or tablet capable of downloading a mobile app * Have verbally and in writing agreed to participate in the study following a briefing about the research Exclusion Criteria: * Visually impaired individuals * Individuals with psychiatric disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for To examine the effects of mobile app support provided to expectant fathers, based on transition theory, on anxiety, bonding with the fetus, and marital harmony are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

To examine the effects of mobile app support provided to expectant fathers, based on transition theory, on anxiety, bonding with the fetus, and marital harmony

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ege University

    Izmir, Urla, Turkey (Türkiye)

  • Ege Üniversitesi

    Izmir, Turkey (Türkiye)